DSCAM and Down syndrome: Further studies revealed abnormalities in the DSCAM signalling pathway, and knockdown of the DSCAM gene or inhibition of the PAK1 signalling pathway using CRISPR/CAS9 rescued the phenotype related to cortical developmental defects in Down's syndrome.